Co-Authors
This is a "connection" page, showing publications co-authored by Torsten Stelzer and Cornelis Vlaar.
Connection Strength
0.398
-
Jim?nez Cruz JM, Vlaar CP, L?pez-Mej?as V, Stelzer T. Solubility Measurements and Correlation of MBQ-167 in Neat and Binary Solvent Mixtures. J Chem Eng Data. 2021 Jan 14; 66(1):832-839.
Score: 0.193
-
Rodr?guez-Fern?ndez K, Reynaldo-Fern?ndez G, Reyes-Gonz?lez S, de Las Barreras C, Rodr?guez-Vera L, Vlaar C, Monbaliu JM, Stelzer T, Duconge J, Mangas-Sanjuan V. New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model. Biomed Pharmacother. 2024 Jan; 170:115977.
Score: 0.059
-
Jim?nez Cruz JM, Vlaar CP, Stelzer T, L?pez-Mej?as V. Polymorphism in early development: The account of MBQ-167. Int J Pharm. 2021 Oct 25; 608:121064.
Score: 0.051
-
Reyes-Gonz?lez S, de Las Barreras C, Reynaldo G, Rodr?guez-Vera L, Vlaar C, Mejias VL, Monbaliu JM, Stelzer T, Mangas V, Duconge J. Genotype-driven pharmacokinetic simulations of warfarin levels in Puerto Ricans. Drug Metab Pers Ther. 2020 Aug 19.
Score: 0.047
-
Reyes-Gonz?lez S, de Las Barreras C, Reynaldo G, Rodr?guez-Vera L, Vlaar C, Mejias VL, Monbaliu JM, Stelzer T, Mangas V, Duconge J. Genotype-driven pharmacokinetic simulations of warfarin levels in Puerto Ricans. Drug Metab Pers Ther. 2020 08 18; 35(4).
Score: 0.047